Researchers reported a technical success rate of 100%, but they did urge caution if the patient's coaptation gap size exceeds 8.4 mm. 

With older heart valves, a higher degree of aortic angulation was often associated with post-TAVR complications. 

The study's authors emphasized how important it is for clinicians to work together to determine the best treatment strategy. 

The new device was designed to treat LAA occlusion or closure patients with atrial fibrillation who face a high risk of stroke.

AFib patients undergoing cardiac surgery may benefit from concomitant LAAO, according to a new study in the New England Journal of Medicine.

The study, published in the American Journal of Cardiology, included data from nearly 20,000 patients treated in 2016 and 2017. 

According to the real-world analysis, treatment with TriClip was associated with no major adverse events and a procedural success rate of 100%. 

“This survey gives the cardiology community clearer insights into how to enhance the conversations we are already having and align on patient priorities," one specialist said.